Atlas Trials

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer

Clinical trial NCT02447263 · COMPLETED

Trial details

NCT number
NCT02447263
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
2015-05-01
Primary completion
2016-02-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.